# Meningococcal Vaccination in Patients on Complement Inhibitors

> **NCT06906692** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 35 (estimated)

## Conditions studied

- Myasthenia Gravis Generalised
- Vaccination
- Complement System
- Neuromyelitis Optica Spectrum Disease (NMOSD)

## Interventions

- **DIAGNOSTIC_TEST:** Serum Bactericidal Assay

## Key facts

- **NCT ID:** NCT06906692
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-25
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06906692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06906692, "Meningococcal Vaccination in Patients on Complement Inhibitors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06906692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*